AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients

RecruitingNAAges 5 Years - 60 YearsAllSouth Valley University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Mycobacterium leprae is a slow-growing bacillus that causes leprosy. the infection may take two to ten years to incubate. While the exact mechanism of infection transmission is unknown, direct bacillus absorption through the nasal or respiratory mucosa and aerosolized nasal secretions are the most common theories. The bacteria is subsequently transported by the bloodstream to the peripheral nerves, where it can result in tissue damage from painless burns and ulcers as well as irreparable nerve damage that results in a loss of protective feeling.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients of both sexes with positive slit skin smear for m.leprae . Exclusion Criteria: * Contraindications to Multi drug therapy : * Patients with hypersensitivity to sulfa . * Patients with hypersensitivity to clofazimine or rifampcin. * pregnant or lactating women.
๐Ÿ’Š

What it tests

  • Dapsone
๐Ÿ“

Where

1 site
Qina University hospital, South Valley University Hospital
Qina, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy